US Stocks
/
Erasca, Inc. Share Price
Erasca, Inc. Share Price

Erasca, Inc. Share Price

NASDAQ: ERAS | Mid Cap
$16.03
+$0.63 (4.06%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Erasca, Inc. Stock Performance

Open
$15.48
Prev. Close
$15.40
Circuit Range
N/A
Day Range
$15.38 - $16.20
Year Range
$2.10 - $24.28
Volume
4,88,141
Average Traded
$15.80

Erasca, Inc. Share Price Today

As of 10 October 2026, Erasca, Inc.'s share price is $16.03. The stock opened at $15.48, compared to its previous close of $15.40. During today's trading session, Erasca, Inc.'s share price traded between $15.38 and $16.20, with an average price of $15.79. Over the past 52 weeks, the stock has recorded a high of $24.28 and a low of $2.10. In terms of performance, Erasca, Inc.'s share price has risen by 50.66% over the last six months and is up 562.40% on a year-on-year basis.

Erasca, Inc. Share Price Chart

$15.38$16.20
L
Show Current Price
H

Erasca, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.55B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.82
Revenue (TTM)
$0.00
Return On Equity (TTM)
-79.37%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-44.01%

Erasca, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$30.61-$29.09-$183.44-$44.08
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A4.97%-530.59%75.97%

Erasca, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$242.81-$125.04-$161.65-$124.55
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A48.50%-29.28%22.95%

About Erasca, Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

Erasca, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$14.53
$16.08
+9.27%
Sep 2026
$17.64
$14.71
-24.56%
Aug 2026
$17.17
$19.50
+7.52%
Jul 2026
$18.00
$18.14
-1.14%
Jun 2026
$13.17
$18.35
+42.91%
May 2026
$10.39
$12.84
+20.68%
Apr 2026
$16.36
$10.64
-34.20%
Mar 2026
$13.58
$16.17
+18.37%
Feb 2026
$10.51
$13.66
+29.72%
Jan 2026
$3.71
$10.53
+182.31%
Dec 2025
$3.17
$3.73
+17.30%
Nov 2025
$2.40
$3.18
+31.40%

ERAS Share Price FAQs

What is Erasca, Inc. share price today?

chevron-up
Erasca, Inc. share price today is $16.03 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Erasca, Inc. stock?

chevron-up
The 52 week high of Erasca, Inc. stock is $24.28, while the 52 week low is $2.10 as of 10 Oct '26.

What is ERAS's market capitalisation today?

chevron-up
ERAS market capitalisation is $4.55B as of October 10, 2026, at 9:10 am IST.

What is ERAS's net income for the last quarter?

chevron-up
ERAS's net income for the last quarter is -44.08B USD.

What is the 5 year returns of ERAS?

chevron-up
The 5 year returns of ERAS is -18.96% as on 10 Oct '26.

What is the high & low stock price of ERAS today?

chevron-up
ERAS stock price hit a high of $16.20 and low of $15.38 as of 10 Oct '26.

Can I buy ERAS shares in India?

chevron-up
Yes. You can buy ERAS in India by opening an international trading account.